[1]
2018. METASTATIC CHOLANGIOCARCINOMA AS A TARGET OF MOLECULAR-DIRECTED THERAPY. Voprosy onkologii. 64, 5 (May 2018), 671–677. DOI:https://doi.org/10.37469/0507-3758-2018-64-5-671-677.